DigestRedComo funciona
Red
/
Empresas
HA
No verificado

HAYA Therapeutics

Sobre qué escribimos

BiotecnologíaCardiologíaCienciaMedicina - VariosSalud

5 Comunicados de prensa

Ver todos los comunicados de prensa
20/05/2026
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Cardiología
Medicina alternativa
Salud
Industria
HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001, an Investigational Precision Cellular Reprogramming Therapy for Cardiac Fibrosis
Fuente
HAYA Therapeutics
Editor
Business Wire
1.00
0
03/06/2025
HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs® to Accelerate Development of RNA-Guided Therapeutics Platform
Fuente
HAYA Therapeutics
Editor
Business Wire
1.00
0
13/03/2025
HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer
Fuente
HAYA Therapeutics
Editor
Business Wire
1.00
0
11/09/2024
Multimedia
Mercado laboral
Cardiología
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Ciencia
Medicina - Varios
HAYA Therapeutics Appoints Cardiology and Genetics Medicines Expert Jordan Shin, M.D., Ph.D. as Chief Medical Officer
Fuente
HAYA Therapeutics
Editor
Business Wire
1.00
0
01/07/2024
HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award
Fuente
HAYA Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0